遭內地反壟斷處罰 閱文(00772.HK)回應指積極整改及做好合規申報
內媒報道,就遭到反壟斷調查罰款一事,閱文集團(00772.HK)回應指收到通知並高度重視,已嚴格按照監管部門的要求,積極整改,全面做好相關的合規申報工作。
內地市場監管總局根據《反壟斷法》規定,對阿里巴巴(09988.HK)投資收購銀泰商業股權、閱文收購新麗傳媒股權、深圳市豐巢網絡技術收購中郵智遞科技股權等三宗未依法申報違法實施經營者集中案進行了調查。
監管局於今日(14日)依據《反壟斷法》第48條、49條作出處罰決定,對阿里巴巴投資、閱文和深圳市豐巢網絡技術分別處以50萬元人民幣罰款的行政處罰。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.